Skip header and navigation

3 records – page 1 of 1.

[3 cases of viral carriage detected during screening for HIV antibodies].

https://arctichealth.org/en/permalink/ahliterature226768
Source
Zh Mikrobiol Epidemiol Immunobiol. 1991 Mar;(3):16-8
Publication Type
Article
Date
Mar-1991
Author
E M Shelukhina
E V Chekunova
G R Matsevich
I A Okunev
S S Marennikova
M R Zak
Source
Zh Mikrobiol Epidemiol Immunobiol. 1991 Mar;(3):16-8
Date
Mar-1991
Language
Russian
Publication Type
Article
Keywords
Acquired Immunodeficiency Syndrome - epidemiology - immunology - prevention & control
Blood Donors
Carrier State - epidemiology - immunology - prevention & control
Enzyme-Linked Immunosorbent Assay
HIV Antibodies - blood
HIV Seropositivity - epidemiology - immunology
HIV-1 - immunology
Humans
Immunoblotting
Lithuania - epidemiology
Mass Screening - methods
Moscow - epidemiology
Risk factors
Abstract
The results of screening more than 23,000 serum samples from persons belonging to risk groups, as well as those not belonging to such groups, in Moscow, Vilnius and Klaipeda are presented. Screening was carried out with the use of an assay system manufactured by the Scientific and Industrial Amalgamation "Antigen" (USSR). In this screening 3 HIV carriers were detected; of these, 2 were foreign students from two African countries.
PubMed ID
1872091 View in PubMed
Less detail

Optimal serotype compositions for Pneumococcal conjugate vaccination under serotype replacement.

https://arctichealth.org/en/permalink/ahliterature262836
Source
PLoS Comput Biol. 2014 Feb;10(2):e1003477
Publication Type
Article
Date
Feb-2014
Author
Markku Nurhonen
Kari Auranen
Source
PLoS Comput Biol. 2014 Feb;10(2):e1003477
Date
Feb-2014
Language
English
Publication Type
Article
Keywords
Algorithms
Carrier State - epidemiology - immunology - prevention & control
Child
Child, Preschool
Computational Biology
Finland - epidemiology
Humans
Incidence
Models, Immunological
Pneumococcal Infections - epidemiology - immunology - prevention & control
Pneumococcal Vaccines - immunology - therapeutic use
Serotyping
Streptococcus pneumoniae - classification - immunology
Treatment Outcome
Vaccines, Conjugate - immunology - therapeutic use
Abstract
Pneumococcal conjugate vaccination has proved highly effective in eliminating vaccine-type pneumococcal carriage and disease. However, the potential adverse effects of serotype replacement remain a major concern when implementing routine childhood pneumococcal conjugate vaccination programmes. Applying a concise predictive model, we present a ready-to-use quantitative tool to investigate the implications of serotype replacement on the net effectiveness of vaccination against invasive pneumococcal disease (IPD) and to guide in the selection of optimal vaccine serotype compositions. We utilise pre-vaccination data on pneumococcal carriage and IPD and assume partial or complete elimination of vaccine-type carriage, its replacement by non-vaccine-type carriage, and stable case-to-carrier ratios (probability of IPD per carriage episode). The model predicts that the post-vaccination IPD incidences in Finland for currently available vaccine serotype compositions can eventually decrease among the target age group of children
Notes
Cites: Lancet. 2011 Dec 3;378(9807):1962-7321492929
Cites: PLoS One. 2012;7(6):e3973022761879
Cites: PLoS One. 2013;8(2):e5607923457504
Cites: Nat Genet. 2013 Jun;45(6):656-6323644493
Cites: PLoS Med. 2013;10(9):e100151724086113
Cites: J R Soc Interface. 2013 Dec 6;10(89):2013078624132203
Cites: Am J Epidemiol. 2013 Nov 1;178(9):1488-9524013204
Cites: J Infect Dis. 2001 Aug 15;184(4):451-911471103
Cites: J Clin Microbiol. 2007 Apr;45(4):1225-3317267625
Cites: J Infect Dis. 2008 Dec 15;198(12):1818-2218983249
Cites: BMC Infect Dis. 2008;8:17319116005
Cites: Pediatrics. 2009 Jul;124(1):e1-1119564254
Cites: J Infect Dis. 2010 Jan 1;201(1):32-4119947881
Cites: BMC Infect Dis. 2010;10:9020377886
Cites: Vaccine. 2010 Dec 16;29(2):283-821029807
Cites: Epidemics. 2010 Jun;2(2):80-421031138
Cites: PLoS Med. 2011 Apr;8(4):e100101721483718
Cites: Epidemiology. 2011 Mar;22(2):199-20721646962
Cites: Lancet Infect Dis. 2011 Oct;11(10):760-821621466
Cites: Vaccine. 2011 Oct 19;29(45):8042-821871518
Cites: Vaccine. 2011 Nov 8;29(48):8870-621964055
PubMed ID
24550722 View in PubMed
Less detail